ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

VC

Virginia Commonwealth University at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Virginia Commonwealth University brings 4 presentations to ACR Convergence 2026 in Orlando. Its work centres on drug safety and care quality, including osteoporosis screening on long-term steroids, HLA testing before allopurinol and severe skin reactions, plus obesity drugs in inflammatory arthritis and nerve pain in sarcoidosis.

OrganizationACR Convergence 2026 Attendance
VC
Virginia Commonwealth University
Richmond, VA
Universities and research institutes
A public research university with schools of medicine and health sciences.
Talk
Tue Nov 10
10:30am–11:00am
Part of Not Your Parents' Sarcoidosis: Beyond Granulomas and Steroids
Sarcoid Small Fiber Neuropathy: The Biggest Pain Is Not Even Granulomatous
W304A-H
Rare and other diseases

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Virginia Commonwealth University

Tell us what you sell and we’ll find the people at Virginia Commonwealth University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction